Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Cerilliant
Johnson and Johnson
Mallinckrodt
Fuji
Covington
Julphar
Deloitte
Medtronic
Accenture

Generated: August 17, 2017

DrugPatentWatch Database Preview

PENICILLIN V POTASSIUM Drug Profile

« Back to Dashboard

What is the patent landscape for Penicillin V Potassium, and when can generic versions of Penicillin V Potassium launch?

Penicillin V Potassium is a drug marketed by Ivax Sub Teva Pharms, Mylan, Am Antibiotics, Aurobindo Pharma, Dava Pharms Inc, Hikma Pharms, Purepac Pharm, and Sandoz. and is included in thirteen NDAs.

The generic ingredient in PENICILLIN V POTASSIUM is penicillin v potassium. There are eighty-seven drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the penicillin v potassium profile page.

Summary for Tradename: PENICILLIN V POTASSIUM

Patents:0
Applicants:8
NDAs:13
Suppliers / Packagers: see list24
Bulk Api Vendors: see list42
Clinical Trials: see list703
Patent Applications: see list1,580
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PENICILLIN V POTASSIUM at DailyMed

Pharmacology for Tradename: PENICILLIN V POTASSIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ivax Sub Teva Pharms
PENICILLIN V POTASSIUM
penicillin v potassium
TABLET;ORAL060518-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Purepac Pharm
PENICILLIN V POTASSIUM
penicillin v potassium
FOR SOLUTION;ORAL061758-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Sandoz
PENICILLIN V POTASSIUM
penicillin v potassium
TABLET;ORAL064071-002Nov 30, 1995ABRXNoYes► Subscribe► Subscribe► Subscribe
Am Antibiotics
PENICILLIN V POTASSIUM
penicillin v potassium
TABLET;ORAL061528-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Mylan
PENICILLIN V POTASSIUM
penicillin v potassium
FOR SOLUTION;ORAL061624-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
McKinsey
McKesson
Fuji
Cerilliant
Teva
US Army
Federal Trade Commission
Accenture
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot